DL-Isocitric Acid Trisodium Salt Hydrate: Properties & Uses
DL-Isocitric Acid Trisodium Salt Hydrate: Properties & Uses
DL-Isocitric acid trisodium salt hydrate is a water-soluble sodium salt form of the tricarboxylic acid cycle intermediate isocitric acid, widely used as a substrate and reference standard in enzymology, metabolic flux studies, and biochemical assay development.
- Chemical Name
- DL-Isocitric acid trisodium salt hydrate
- SKU
- I106830B
- Molecular Formula (anhydrous free acid)
- C₆H₈O₇ (free acid); trisodium salt hydrate form varies with hydration state
- Solubility
- Freely soluble in water; recommended to prepare fresh aqueous solutions for assays
- Primary Application
- Substrate for isocitrate dehydrogenase (IDH) assays and TCA cycle research
- Storage
- Store at 2–8 °C, protected from moisture and light
Chemical Identity and Physical Properties
DL-Isocitric acid trisodium salt hydrate is the trisodium salt of isocitric acid (threo-Ds-isocitric acid racemic mixture), supplied as a hydrated crystalline solid. Isocitric acid is a six-carbon tricarboxylic acid (C₆H₈O₇ in its free-acid form) bearing three carboxylate groups and one hydroxyl group. The trisodium salt form neutralises all three carboxylic acid moieties, replacing the acidic protons with sodium cations, which dramatically improves aqueous solubility compared with the free acid and facilitates precise gravimetric preparation of working solutions at physiologically relevant pH ranges.
The DL designation indicates that the material is a racemic mixture of the D- and L-enantiomers at the C-2 position (the isocitrate chiral centre acted upon by isocitrate dehydrogenase). Researchers requiring stereospecific enzymatic activity should note that only the naturally occurring threo-Ds-(−)-isocitrate enantiomer serves as the productive substrate for mammalian IDH1, IDH2, and IDH3 enzymes; nevertheless, the DL-racemate is routinely employed in assay development and calibration because of its ready commercial availability and stability.
Role in the Tricarboxylic Acid (TCA) Cycle
Isocitrate is the third intermediate of the tricarboxylic acid (Krebs) cycle. Within the cycle, citrate is first converted to isocitrate by aconitase (EC 4.2.1.3), and isocitrate is then oxidatively decarboxylated to α-ketoglutarate (2-oxoglutarate) by isocitrate dehydrogenase (IDH; EC 1.1.1.41 for NAD⁺-dependent IDH3; EC 1.1.1.42 for NADP⁺-dependent IDH1/IDH2), generating CO₂ and the reduced cofactor NADH or NADPH. This step is considered one of the key regulatory nodes of the TCA cycle.
DL-Isocitric acid trisodium salt hydrate enables researchers to supply exogenous isocitrate directly to cell-free systems, isolated mitochondria, or purified enzyme preparations without the need to generate the substrate in situ. This capability is essential for measuring IDH kinetic parameters (Km, Vmax, kcat), studying allosteric regulation by ADP and NADH, and investigating gain-of-function IDH mutations associated with oncometabolite 2-hydroxyglutarate (2-HG) production.
Laboratory Applications
Enzyme Activity Assays: The most common application is as a direct substrate in spectrophotometric IDH activity assays. The reaction is monitored at 340 nm by tracking the increase in NADH or NADPH absorbance. The trisodium salt dissolves readily in assay buffer, enabling accurate concentration determination by weight.
Metabolic Flux Analysis: Isotopically labelled analogues aside, unlabelled DL-isocitrate trisodium salt is used to validate metabolic flux models, calibrate LC-MS/MS quantitation methods for TCA-cycle metabolite panels, and serve as an authentic reference standard for isocitrate peak identification.
Mitochondrial Function Studies: Adding exogenous isocitrate to isolated mitochondria supplements the TCA cycle substrate pool, enabling assessment of respiratory chain coupling, ATP synthesis rates, and the effect of pharmacological inhibitors on oxidative phosphorylation.
IDH Mutation Research: Cancer-associated IDH1/IDH2 neomorphic mutations (e.g., R132H, R172K) convert isocitrate to 2-HG instead of α-ketoglutarate. DL-Isocitric acid trisodium salt hydrate is used as a substrate to measure mutant IDH activity and to screen inhibitor compounds in biochemical assays.
Preparation, Handling, and Storage
Solution Preparation: Weigh the required amount under ambient conditions and dissolve in ultrapure water or the appropriate assay buffer (e.g., 50 mM Tris-HCl, pH 7.4, or 100 mM potassium phosphate, pH 7.4). Because the trisodium salt is fully ionised at physiological pH, no pH adjustment is typically required for dilute solutions; however, for concentrated stock solutions (>100 mM), verify and adjust pH as needed. Prepare fresh solutions on the day of the experiment or aliquot and store at −20 °C to minimise degradation.
Handling Precautions: Use standard laboratory personal protective equipment (lab coat, nitrile gloves, safety glasses). Avoid inhalation of dust when weighing the powder. The compound does not carry acute toxicity classifications typical of hazardous chemicals, but good laboratory practice should be observed at all times.
Storage Conditions: Store the bulk solid at 2–8 °C in a tightly sealed container protected from moisture and light. Under these conditions, the reagent is expected to retain activity for the duration of the stated shelf life. Do not store near strong oxidising agents or acids.
Quality Considerations and Purchasing Guidance
When selecting DL-Isocitric acid trisodium salt hydrate for sensitive biochemical assays, researchers should consider the following quality attributes: purity (typically ≥98% by titration or HPLC for research-grade material), identity confirmation (IR or NMR spectrum), water content (Karl Fischer titration to confirm hydration state), and heavy-metal impurity levels. Lot-specific certificates of analysis (CoA) should be requested to verify these parameters prior to use in critical experiments.
Aladdin Scientific's I106830B is supplied for research use. Researchers involved in regulated studies (e.g., IVD assay development, GMP environments) should consult with their quality assurance teams regarding suitability and additional documentation requirements. For bulk quantities or custom purity specifications, contact Aladdin Scientific's technical sales team directly.
Frequently asked questions
What is the difference between DL-isocitric acid trisodium salt and the free acid form?
The trisodium salt has all three carboxylic acid groups neutralised by sodium ions, making it far more soluble in water and easier to weigh accurately for solution preparation. The free acid form is more hygroscopic and requires careful pH adjustment after dissolution. For most biochemical assays, the trisodium salt hydrate is the preferred form because of its handling convenience and solution stability.
Can DL-isocitric acid trisodium salt hydrate be used as a substrate for stereospecific IDH assays?
The DL-racemate contains both the naturally occurring D-enantiomer (the productive IDH substrate) and the L-enantiomer. For standard activity and kinetic assays where absolute stereospecificity is not required, the DL-salt is widely used and well-accepted. If the assay requires only the natural D-isocitrate enantiomer, researchers should verify whether a single-enantiomer product is available or account for the 50% active substrate content when calculating kinetic constants.
How should I store prepared isocitrate solutions to maintain stability?
Prepared aqueous solutions of DL-isocitric acid trisodium salt should be stored at −20 °C in aliquots to avoid repeated freeze-thaw cycles. Solutions should be used within the same day if kept at room temperature or at 4 °C. Avoid storage at alkaline pH for extended periods, as isocitrate can undergo non-enzymatic interconversion with citrate and aconitate under certain conditions.
What spectrophotometric wavelength is used to monitor IDH activity with this substrate?
IDH activity using isocitrate as substrate is typically monitored at 340 nm, where NADH and NADPH absorb strongly (molar extinction coefficient ε ≈ 6,220 M⁻¹cm⁻¹). An increase in absorbance at 340 nm over time directly corresponds to the reduction of NAD⁺ or NADP⁺ and thus reflects IDH catalytic activity.
Is I106830B suitable for use in cell culture or in vivo studies?
DL-Isocitric acid trisodium salt hydrate from Aladdin Scientific (I106830B) is supplied for research use only and is not intended for clinical, diagnostic, or therapeutic applications. For cell culture supplementation or in vivo metabolic studies, researchers should confirm the purity grade, sterility requirements, and absence of endotoxins, and consult the product CoA. Cell permeability of isocitrate is limited, so cell-free or mitochondrial systems are the most common experimental contexts.
References
- Krebs HA, Johnson WA. The role of citric acid in intermediate metabolism in animal tissues. Enzymologia. 1937;4:148–156.
- Dang L, White DW, Gross S, et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature. 2009;462:739–744. doi:10.1038/nature08617
- Plaut GWE, Cook M, Aogaichi T. The subcellular location of isozymes of NADP-isocitrate dehydrogenase in tissues from several organisms. Biochimica et Biophysica Acta. 1983;760:300–308.
- Lowenstein JM. Methods in Enzymology, Vol. 13: Citric Acid Cycle. Academic Press; 1969.
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)